Related Experiment Videos
Protein S deficiency in sickle cell anemia
1Department of Medicine, University of Southern California School of Medicine, Los Angeles.
The Journal of Laboratory and Clinical Medicine
|May 1, 1988
Summary
Sickle cell disease is linked to lower levels of protein S, a key anticoagulant. This study found reduced free protein S in most patients, suggesting a potential role in disease pathophysiology.
Area of Science:
- Hematology
- Coagulation Disorders
Background:
- Sickle cell disease (SCD) is a genetic blood disorder associated with thrombotic complications.
- The protein C-protein S anticoagulant pathway plays a crucial role in regulating blood coagulation.
Purpose of the Study:
- To investigate the status of the protein C-protein S anticoagulant pathway in individuals with sickle cell disease.
- To determine levels of protein C, total and free protein S, and C4b-binding protein in SCD patients.
Main Methods:
- Measurement of protein C, total and free protein S, and C4b-binding protein levels in 20 SCD subjects (Hb SS or SC).
- Comparison of levels with normal individuals.
- Crossed immunoelectrophoresis used for plasma samples from eight SCD subjects.
Main Results:
- Significantly lower mean total and free protein S levels were observed in SCD subjects compared to normal individuals.
- Free protein S levels were more markedly reduced than total protein S levels.
- Mean protein C activity was normal, but four subjects had levels below normal range on at least one occasion.
- C4b-binding protein levels were normal, and no correlation was found with free protein S levels.
Conclusions:
- Sickle cell disease is associated with reduced levels of protein S, particularly the free form.
- The observed reduction in free protein S is not attributed to increased C4b-binding protein levels.
- Further research is warranted to explore the implications of protein S deficiency in SCD pathophysiology and thrombotic risk.